2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease

Abstract Background Pompe disease (PD) is an autosomal recessive, lysosomal storage disease due to a mutation of the acid α-glucosidase (GAA) gene. In adult patients, PD is characterized by slowly progressive limb-girdle and trunk myopathy and restrictive respiratory insufficiency. Enzyme replacemen...

Full description

Bibliographic Details
Main Authors: U. Plöckinger, V. Prasad, A. Ziagaki, N. Tiling, A. Poellinger
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Human Genomics
Subjects:
Pompe disease
2-deoxy-2-[18]fluoro-D-glucose PET/CT
Biomarker
MRI
Online Access:http://link.springer.com/article/10.1186/s40246-018-0145-7

Similar Items

Similar Items